Bernhard R. Winkelmann

Author

Also Known As

Alan F. Wright, Andreas Meinitzer, B R Winkelmann, B WINKELMANN, B Winkelmann, B. R. WINKELMANN, B. R. Winkelmann, B. Winkelmann, B.R. WINKELMANN, B.R. Winkelmann

198

Publications

11.2K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University Kardiologie Frankfurt-Sachsenhausen Medical University of Graz Synlab (Germany)Universität Ulm

About

Bernhard R. Winkelmann is an author at Heidelberg University specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	39	3.7K
2	Public Health	26	33	2.4K
3	Health Sciences	3	3	242
4	Allergy	1	1	14
5	Biochemistry	1	1	51

Bernhard R. Winkelmann

Publications

Citations

H-Index

Page 1

	Year	Citations
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, The Lancet ThrombosisCardiovascular DiseaseAtherosclerosisMedicineCoronary Artery Disease	2017	749
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture Sonja I. Berndt, Stefan Gustafsson, Reedik Mägi, Nature Genetics Genome-wide Association StudyGenetic AnalysisGenotype-phenotype AssociationMedicineGenetics	2013	676
Seventy-five genetic loci influencing the human red blood cell Pim van der Harst, Weihua Zhang, Irene Mateo Leach, Nature Seventy-five Genetic LociGeneticsHematologyBlood CellHeme Homeostasis	2012	329
Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study) Andreas Meinitzer, Ursula Seelhorst, Britta Wellnitz, Clinical Chemistry	2006	227
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Journal of the American Heart Association	2016	196
Homoarginine, Cardiovascular Risk, and Mortality Winfried März, Andreas Meinitzer, Christiane Drechsler, Circulation	2010	186
A Genomewide Scan for Early-Onset Coronary Artery Disease in 438 Families: The GENECARD Study Elizabeth R. Hauser, David C. Crossman, Christopher B. Granger, The American Journal of Human Genetics Genome-wide Association StudyEpidemiologyCardiovascular DiseaseAtherosclerosisGenetics	2004	176
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial Guillermo Torre‐Amione, Stefan D. Anker, Robert C. Bourge, The Lancet Non-specific Immunomodulation TherapyHeart FailureChronic Heart FailureAcclaim TrialCardiovascular Disease	2008	176
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction Burkert Pieske, Rolf Wachter, Sanjiv J. Shah, JAMA	2021	155
Low-Density Lipoprotein Triglycerides Associated With Low-Grade Systemic Inflammation, Adhesion Molecules, and Angiographic Coronary Artery Disease Winfried März, Hubert Scharnagl, Karl Winkler, Circulation	2004	150

Page 1